Company profile for CADENCE PHARMS

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. The company holds the rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the ...
Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. The company holds the rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever in adults and children. It distributes its products primarily through drug wholesalers to anesthesiologists and surgeons, as well as nurse anesthetists, emergency medicine physicians, intensivists, internists, hospitalists, obstetricians, and other physicians. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California. As of March 18, 2014, Cadence Pharmaceuticals Inc. operates as a subsidiary of Mallinckrodt plc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
12481 High Bluff Drive Suite 200 San Diego, CA 92130
Telephone
Telephone
+1 858-436-1400
Client Website
Website
--
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240208769811/en

BUSINESSWIRE
08 Feb 2024

https://www.businesswire.com/news/home/20231207130587/en

BUSINESSWIRE
07 Dec 2023

https://www.businesswire.com/news/home/20220901005242/en

BUSINESSWIRE
01 Sep 2022

https://www.businesswire.com/news/home/20220725005392/en

BUSINESSWIRE
25 Jul 2022

https://www.fiercebiotech.com/medtech/telehealth-provider-cadence-debuts-41m-to-bring-hospital-care-home

FIERCEBIOTECH
06 Aug 2021
Mallinckrodt pays $1.2bn for Sucampo Pharma
Mallinckrodt pays $1.2bn for Sucampo Pharma

03 Jan 2018

// Phil Taylor PMLIVE

http://www.pmlive.com/pharma_news/mallinckrodt_pays_$1.2bn_for_sucampo_pharma_1215000

Phil Taylor PMLIVE
03 Jan 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty